2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
-
12/2019 |
2 | Pharmaceutical PreparationsIBA
12/2020
-
11/2020 |
2 | CXCR4 Receptors (CXCR4 Receptor)IBA
11/2020
-
08/2020 |
2 | LigandsIBA
01/2020
-
01/2017 |
2 | CXCR ReceptorsIBA
01/2020
-
12/2019 |
2 | Chemokine ReceptorsIBA
12/2019
-
12/2019 |
1 | CytokinesIBA
01/2021 |
1 | Bile Acids and Salts (Bile Acids)IBA
01/2021 |
1 | Interleukin-6 (Interleukin 6)IBA
01/2021 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 |
1 | PromegaIBA
01/2021 |
1 | Cholinergic Agents (Cholinergics)IBA
12/2020 |
1 | Cholinergic ReceptorsIBA
12/2020 |
1 | ErbB Receptors (EGF Receptor)IBA
08/2020 |
1 | Chemokine CXCL12IBA
08/2020 |
1 | G-Protein-Coupled Receptor Kinase 2IBA
08/2020 |
1 | Purinergic P2 Receptors (ADP Receptor)IBA
03/2020 |
1 | Tyrosine Kinase InhibitorsIBA
01/2020 |
1 | CXC ChemokinesIBA
01/2020 |
1 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2019 |
1 | Tolterodine Tartrate (Detrol)FDA Link
10/2019 |
1 | 5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2017 |
1 | Narcotic Antagonists (Opioid Antagonists)IBA
01/2017 |
1 | Freund's AdjuvantIBA
01/2017 |
1 | Opioid Receptors (Opioid Receptor)IBA
01/2017 |
1 | Naloxone (Narcan)FDA LinkGeneric
01/2017 |
1 | CalciumIBA
01/2017 |
1 | Opioid Peptides (Opioid Peptide)IBA
01/2017 |
1 | 2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
01/2017 |
1 | resolvin D1IBA
01/2017 |
1 | Opioid Analgesics (Opioids)IBA
01/2016 |
1 | Heme (Haem)IBA
01/2011 |
1 | N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
03/2002 |